{
    "nctId": "NCT01900418",
    "briefTitle": "Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy",
    "officialTitle": "Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Joint Pain, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 78,
    "primaryOutcomeMeasure": "Self-reported joint pain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Taking an aromatase inhibitor as adjuvant treatment for State I, II, or II breast cancer for at least 4 weeks\n* Experiencing more than mild joint pain/symptoms\n* 21 or older\n* have permission from physician to engage in moderate intensity physical activity\n\nExclusion Criteria:\n\n* Undergoing chemotherapy and/or radiation therapy at any time during the study period\n* Scheduled for major surgery during the study period\n* Presently engaged in high levels of physical activity on a daily basis\n* Less than 21 years of age\n* Unable to walk or engage in moderate intensity physical activity",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}